Neuropharmagen® is a pharmacogenomics-based precision medicine platform especially developed for psychiatry. It helps optimize the pharmacological treatment based on the patient’s genetic profile, drug-drug interactions and lifestyle and clinico-physiological factors that influence the medication success.

Neuropharmagen® has proven clinical utility, demonstrated by randomized clinical trials that have shown statistically significant improvements on both efficacy and tolerability when compared with treatment as usual.